Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
MMWR. Morbidity and Mortality Weekly Report
|
March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024
Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
Lancet Regional Health. Americas
|
June 19, 2023
Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort study
Katherine Adams, John J Riddles, Elizabeth A K Rowley, et al.
Lancet Regional Health. Americas
|
October 3, 2025
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis
Amanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, et al.
JAMA Network Open
|
June 25, 2025
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults
Ruth Link-Gelles, Elizabeth A K Rowley, Stephanie A Irving, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022
Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Lancet (London, England)
|
October 19, 2024
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis
Amanda B Payne, Janet A Watts, Patrick K Mitchell, et al.
JAMA Internal Medicine
|
June 15, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in Adults
Ryan E Wiegand, Amanda B Payne, Josephine Mak, et al.
MMWR. Morbidity and Mortality Weekly Report
|
March 15, 2023
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022
Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 7, 2023
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness
Alexandra F Dalton, Zachary A Weber, Katie S Allen, et al.
Pediatrics
|
April 7, 2023
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents
Nicola P Klein, Maria Demarco, Katherine E Fleming-Dutra, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
MMWR. Morbidity and Mortality Weekly Report
|
March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024
Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
Lancet Regional Health. Americas
|
June 19, 2023
Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort study
Katherine Adams, John J Riddles, Elizabeth A K Rowley, et al.
Lancet Regional Health. Americas
|
October 3, 2025
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis
Amanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, et al.
JAMA Network Open
|
June 25, 2025
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults
Ruth Link-Gelles, Elizabeth A K Rowley, Stephanie A Irving, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022
Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Lancet (London, England)
|
October 19, 2024
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis
Amanda B Payne, Janet A Watts, Patrick K Mitchell, et al.
JAMA Internal Medicine
|
June 15, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in Adults
Ryan E Wiegand, Amanda B Payne, Josephine Mak, et al.
MMWR. Morbidity and Mortality Weekly Report
|
March 15, 2023
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022
Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 7, 2023
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness
Alexandra F Dalton, Zachary A Weber, Katie S Allen, et al.
Pediatrics
|
April 7, 2023
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents
Nicola P Klein, Maria Demarco, Katherine E Fleming-Dutra, et al.
Page
of 6